Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
54.3M
-
Number of holders
-
92
-
Total 13F shares, excl. options
-
48.6M
-
Shares change
-
+1.84M
-
Total reported value, excl. options
-
$633M
-
Value change
-
+$9.52M
-
Number of buys
-
52
-
Number of sells
-
-37
-
Price
-
$13.03
Significant Holders of Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX) as of Q1 2025
111 filings reported holding BCAX - Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share as of Q1 2025.
Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.6M shares
of 54.3M outstanding shares and own 89.36% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (6.96M shares), FMR LLC (3.61M shares), Siren, L.L.C. (3.27M shares), RED TREE MANAGEMENT, LLC (3.17M shares), TPG GP A, LLC (3.01M shares), Vestal Point Capital, LP (2.77M shares), Omega Fund Management, LLC (2.2M shares), BRAIDWELL LP (2.16M shares), Deep Track Capital, LP (2M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1.8M shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.